Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

LuxembourgBack to Luxembourg

Clinical trials in Luxembourg

8 clinical trials in Luxembourg, Luxembourg across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Luxembourg at a glance
8
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

8 trials in Luxembourg

Open in trial search

Parkinson's disease

Recruiting

Efficacy of intravenous prasinezumab versus placebo in Parkinson's disease patients with severe GBA mutation: a 104‑week randomized double‑blind study

Registered drug
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:Universitaetsklinikum Tuebingen AöR

Acute coronary syndrome+1

Recruiting

Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly Patients or Those at Risk of Bleeding After Balloon Surgery

Registered drugNo placebo
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fondazione Ricerca e Innovazione Cardiovascolare

Study on the Safety and Effectiveness of NVD-003 Implant for Adults with Difficult-to-Heal Lower Leg Bone Fractures

Recruiting
InvestigationalNo placebo
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Adipose-Derived Stem Cells
  • Sponsor:Novadip Biosciences

Radius fracture

Recruiting

Study on Long-term Safety of NVDX3 Implant for Patients with Distal Radius Fracture or Low-grade Degenerative Lumbar Spondylolisthesis

InvestigationalNo placebo
Countries:LuxembourgLuxembourg
  • Participants:18–64 years
  • Substances:NVDX3
  • Sponsor:Novadip Biosciences

Small cell lung cancer extensive stage

Not yet recruiting

Study on the Effectiveness of Paclitaxel, Carboplatin, and Durvalumab for Patients with Extensive Stage Small Cell Lung Cancer

Registered drugNo placebo
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique

Parkinson's disease

Not recruiting

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Investigational
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:F. Hoffmann-La Roche AG

Lung disorder

Not recruiting

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Oslo University Hospital HF

Lung disorder

Not recruiting

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Investigational
Countries:LuxembourgLuxembourg
  • Participants:18–64 years · 65+ years
  • Substances:Bemcentinib
  • Sponsor:Oslo University Hospital HF

Other cities in Luxembourg

The busiest research cities in the country

All 2 cities in Luxembourg

Clinical research in Luxembourg

What the registry says about research in the country

01 Orthopedic Research

Innovative studies focusing on bone reconstruction and healing, particularly examining advanced treatment options for challenging limb conditions and fractures.

  • Lower limb nonunion treatment
  • Lumbar spondylolisthesis therapy
  • Distal radius fracture management

Research emphasizes novel osteogenic implants and their long-term safety profiles in various skeletal conditions.

02 Neurology Studies

Ground-breaking research in Parkinson's disease treatment, investigating new therapeutic approaches for early-stage patients.

  • Motor progression assessment
  • Novel drug interventions
  • Early-stage disease management

Trials focus on evaluating innovative treatments to slow disease progression and improve patient outcomes.

03 Oncology Research

Advanced studies in Small Cell Lung Cancer treatment, exploring combination therapies for extensive disease states.

  • First-line therapy evaluation
  • Immunotherapy combinations
  • Systemic treatment approaches

Research aims to enhance treatment efficacy through innovative drug combinations.

04 Infectious Disease Studies

Comprehensive research on COVID-19 treatments, investigating multiple therapeutic approaches for varying disease severities.

  • Moderate COVID-19 management
  • Severe disease intervention
  • Immunocompromised patient care

Trials evaluate novel therapeutic agents and their efficacy in different patient populations.

Back to LuxembourgAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.